About Diabetes
Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.
Frequently Asked Questions
How can I find information on impact factor, lead times, etc.?
How can I submit a paper to Diabetes?
How can I contact the editorial office about a paper I've submitted?
How can I get permission to use copyrighted material from the journal?
How can I join ADA and become a Professional Member?
Whom can I contact with membership/subscription questions?
Whom should I contact with advertising questions or to request a media kit?
What are Diabetes'editorial policies?
How can I find information on impact factor, lead times, etc.?
Click here for Diabetes' vital statistics.
How can I submit a paper to the journal?
Please see the instructions for authors for complete submission information.
How can I contact the editorial office about a paper I've submitted?
You can check the status of your submission online at http://mc.manuscriptcentral.com/diabetes.
To reach the editorial office directly, please use the following contact information:
E-mail: diabetesjournal{at}diabetes.org
Phone: (310) 794-2858
Fax: (310) 794-3982
If you have been asked to send something to the editorial office, please use the following address (please note that Diabetes only takes manuscript submissions via the Web; see above):
Diabetes Editorial Office
David Geffen School of Medicine at UCLA
Dept. of Med-Endo
Box 957073, 24-141 Warren Hall
Los Angeles, CA 90095-7073
How can I get permission to use copyrighted material from the journal?
Please click on "Get Permissions" to the right of the online version of an article. All permission requests, with the exception
of translations, are processed through Copyright Clearance Center, and most are completed within 5 to 10 business days. For permission to translate, please send an e-mail containing the volume,
issue, and page range of the article, the language, and the quantity to permissions{at}diabetes.org.
How can I order reprints?
Commercial reprint and e-print quote and order requests (quantities of 100 or more) should be directed to:
Hope Robinson
Content Sales Specialist
Sheridan Content Services
Phone: 800-635-7181 ext. 8065
E-mail: hope.robinson{at}sheridan.com
Individual or small-quantity reprints and e-prints(quantities of 1-99) can be ordered by clicking "Purchase This Article" to the right of the online version of an article.
How can I subscribe?
Click here for subscription information.
How can I join ADA and become a Professional Member?
To become a Professional Member, you can access the Membership Application here, and see 8 reasons to join here. After filling out the form, it can either be e-mailed to "membership{at}diabetes.org", or mailed to the address listed on the form.
For more information on becoming an ADA professional member, please visit http://www.diabetes.org/membership/professional.jsp.
Whom can I contact with membership/subscription questions?
American Diabetes Association
Membership/Subscription Services
1701 N. Beauregard St.
Alexandria, VA 22311
phone: toll-free 1-800-232-3472 ext. 2343; outside the U.S., 703-549-1500 ext. 2343, Monday through Friday 8:30 a.m. to
8:30 p.m. ET
fax: 703-549-6995
e-mail: membership{at}diabetes.org
Whom should I contact with advertising questions or to request a media kit?
Pharmaceutical/Device Advertisers
Joe Jackson, bartjack{at}aol.com
Paul Nalbandian, pnalbandian4ada{at}aol.com
Tina Auletta, jggtina@aol.com
The Jackson-Gaeta Group Inc.
33 Smull Avenue
Caldwell, NJ 07006
Office: (973) 403-7677
Fax: (973) 403-7837
Consumer Advertisers
Nancy Greenwald, Vice President, Advertising Sales & Custom Media,
ngreenwald@adamediasales.com
Office: (646) 783-3786
Fax: (212) 486-0315
Northeast/Southeast/Westcoast: Nancy Greenwald, ngreenwald@adamediasales.com
Midwest: Kevin Zoeller, kevin{at}zoellermediasales.com; Angelina Moise, angelina{at}zoellermediasales.com
Zoeller Media Sales Inc.
35 East Wacker Drive
Chicago, IL 60601
Office: 312-782-8855
Fax: 312-782-8857
Digital
eHealthcare Solutions LLC
810 Bear Tavern Road
Ewing, NJ 08628
(609) 882-8887 ext.1
sales{at}e-healthcaresolutions.com
ADA Advertising Production Contact
Julie DeVoss Graff, Advertising Manager, jdevoss@diabetes.org
The advertising rate card can be found HERE.
What are Diabetes' editorial policies?
ADA's Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for Diabetes have been adopted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of Diabetes. Comprehensive information related to the editorial and ethical policies of Diabetes can be found in Publication Policies and Procedures for Diabetes. The Association's Publications Policy Committee or Subcommittee on Ethical Scientific Publications will consider on a case-by-case basis policies that are not addressed in the policies document, which contains information related to the following topics:
- Study Design
- Originality and Prior Publication
- Authorship and Contributions
- Acknowledgments
- Conflict of Interest
- Clinical Trials, Systematic Reviews, and Meta-Analyses
- Plagiarism
- Digital Image Manipulation
- Responses to Possible Scientific Misconduct
- Peer Review
- Editorial Decisions
- Prepublication of Accepted Articles
- Reuse, Post-Prints, and Public Access
- Errata
- Media Embargos
- Advertising
- Supplements
